{"nct_id":"NCT02585778","title":"Efficacy and Safety of Alirocumab Versus Placebo on Top of Maximally Tolerated Lipid Lowering Therapy in Patients With Hypercholesterolemia Who Have Type 1 or Type 2 Diabetes and Are Treated With Insulin (ODYSSEY DM - Insulin)","status":"COMPLETED","status_verified_date":"2018-04","start_date":"2015-10-23","start_date_type":"ACTUAL","primary_completion_date":"2017-04-03","primary_completion_date_type":"ACTUAL","completion_date":"2017-04-03","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["SNY"]}